DUBLIN, March 10, 2021 / PRNewswire / – Added Report “Global Neurovascular Intervention Devices Market – Estimated to 2027” ResearchAndMarkets.com’s offering.
The global Neurovascular Intervention Equipment market is expected to grow at a single-digit high CAGR $ 4,167.4 million ro 2027.
Over the decade, as a result of the technological advances with emerging and innovative technologies deployed under such minimally invasive conditions, neurovascular interventions have developed rapidly. As a result of rapid advances, there is a significant expansion in the potential therapeutic application for neurovascular diseases.
Neurovascular intervention devices are used to treat intracranial aneurysm, ischemic stroke, arteriovenous malformation, carotid stenosis and other diseases such as intracranial stenosis, dural fistula. The market is mainly driven by the increase in the incidence and frequency of neurovascular diseases such as intracranial aneurysm, stroke and arteriovenous malformations, increase in aging population, technological advancement, erection and rehabilitation. favorable returns and factors such as product recall, problems with applied devices, lack of skilled and educated professionals, emerging alternatives such as stem cell treatments, radiation treatments and also policies strict regulation for product approval as a result of the classification of neurovascular interventions as class II and III devices and thus inhibits market growth.
Key topics covered:
1 Executive Minutes
2 Introduction
2.1 Main Takeaways
2.2 Scope of report
2.3 Description of the report
2.4 Markets covered
2.5 Stakeholders
2.6 Research Methodology
3 Market Analysis
3.1 Introduction
3.2 Market definition
3.3 Factors influencing the market
3.3.1 Drivers and Opportunities
3.3.1.1 Increase in the incidence and frequency of neurovascular diseases
3.3.1.2 Technological Advances in Aggressive Small Products
3.3.1.3 Favorable Repayment Policies
3.3.1.4 Increase in the aging population
3.3.1.5 Acquisition and Partnerships as part of the Growth Strategy
3.3.2 Barriers and Risks
3.3.2.1 Adverse events and complications with neurovascular intervention device signals
3.3.2.2 Lack of skilled and trained professionals
3.3.2.3 Product Recall
3.3.2.4 Strict Management Policies
3.3.2.5 Access to Other Outcomes
3.4 Regulatory Issues
3.4.1 International Organization for Standardization
3.4.1.1 Iso 9001: 2015 Quality Management System
3.4.1.2 Medical Devices Iso 13485
3.4.1.3 Iso 10993 Biological Assessment of Medical Devices
3.4.2 and SA
3.4.3 Canada
3.4.4 Europe
3.4.5 Japan
3.4.6 China
3.4.7 India
3.5 Repayment Situation
3.5.1 Repayment Schedule
3.6 funding position
3.7 Patent Movements
3.8 Technological Advances
3.8.1 Introduction
3.8.2 Advances in Thrombectomy Instruments
3.8.3 Embolization
3.8.4 Melt embolization
3.8.5 Diverter streaming
3.8.6 Other tools
3.9 Outcome agreement
3.10 Porter Force Five Study
3.11 Supply chain analysis
3.12 Market segment analysis with key players
3.12.1 Analysis of the market segment of neurovascular intervention devices
3.12.2 Coils market market analysis
3.12.3 Global Flow Diverters Market Share Analysis
3.12.4 Market analysis of intracranial stent market segment
3.12.5 Global Carotid Stent Market Share Analysis
3.12.6 Stent Retriever market segment analysis
3.12.7 Global catheters desire market analysis
3.12.8 Global Liquid Embolics Market Share Analysis
3.13 Neurovascular Intervention Number of units by area
3.13.1 Coils Number of units by area
3.13.2 Embolics Liquid Number of units by area
3.13.3 Stent Retriever Number of units by area
3.13.4 Tools Desire Number of units by area
3.13.5 Intracranial Stents Number of units by area
3.13.6 Carotid Stent Number of units by area
3.14 Neurovascular Intervention Equipment Company Comparison Table by Classification, Results and Applications
3.15 Neurovascular Intervention Equipment Market
4 Global Market of Neurovascular Intervention Devices, by Product
4.1 Introduction
4.2 Arctic Capture Devices
4.2.1 Coils
4.2.1.1 Bare metal coils
4.2.1.2 Coils covered
4.2.2 Melting embolics
4.2.3 Streaming diverters
4.2.4 Stream Breaking
4.2.5 Other
4.3 Stents
4.3.1 Intracranial Stents
4.3.1.1 Stenosis Stents
4.3.1.2 Stentan Coil Aneurysm
4.3.2 Carotid Stents
4.4 Thrombectomy Instruments
4.4.1 Recipients
4.4.2 Desire Tools
4.5 Support tools
5 Global Market of Neurovascular Intervention Devices, by Demand
5.1 Introduction
5.2 Intracranial Aneurysm
5.3 Ischemic Stroke
5.4 Arteriovenous malformation
5.5 Other diseases
6 Regional Analysis
6.1 Introduction
6.2 North America
6.2.1 US
6.2.2 The remainder of North America
6.3 Europe
6.3.1 Germany
6.3.2 RA
6.3.3 France
6.3.4 The rest of Europe
6.4 APAC
6.4.1 Japan
6.4.2 China
6.4.3 India
6.4.4 Remainder of APAC
6.5 Rest of the world
6.5.1 Brazil
6.5.2 The rest of Latin America
6.5.3 Middle East and others
7 Competitive Landscape
7.1 Introduction
7.2 Product Agreement
7.3 Agreements
7.4 Product launch
7.5 Construction
7.6 Other developments
8 Major companies
8.1 Abbott’s Laboratory
8.2 Balt Extraction
8.3 Boston Scientific Corporation
8.4 MacIain & MacIain (Cerenovus)
8.5 Medtronic public limited company
8.6 Microport Scientific Corporation
8.7 Penumbra, Inc.
8.8 Medical Silk Road, Inc.
8.9 Stryker Corporation
8.10 Terumo Corporation
Companies mentioned
- AB Medica Deutschland Verwaltungs GmbH (Germany)
- Abbott Laboratories (US)
- Acandis GmbH (Germany)
- Achieva Medical (China)
- Medical Allium (Israel)
- Anaconda Biomed SL (UK)
- Artio Medical Inc. (US
- Asahi Intecc Co., Ltd (Japan)
- Balt Extraction (France)
- Balton Sp. z oo (Poland)
- Biomerics (US)
- Biomodex (France)
- Boston Scientific Corporation (US)
- Cardiatis
- Cardinal Health, Inc. (US)
- CereVasc, Inc. (US)
- Ceretrieve Limited (Israel)
- Cerus Endovascular (US)
- Contego Medical, LLC (US)
- Cook Medical (US)
- Medical Creganna (US)
- Evasc medical systems (Canada)
- Fluidx Medical Technology (US)
- Imperative Care Inc (US)
- InspireMD (Israel)
- Instylla Inc (US)
- Jiushi Shenkang Medical Technology (China)
- Johnson & Johnson (Cerenovus) (US)
- CORPORATION KANEKA (Japan)
- Kaneka Pharma America LLC (US)
- Lake Medical Department (US)
- MIVI Non-Knowledge (US)
- Medtronic Plc (Ireland)
- Merlin MD Pte. Limited ((Singapore)
- Micro Therapeutics, Inc. (US)
- Microport Scientific Corporation (China)
- Monarch Biosciences, Inc. (Monarch Bio) (US)
- Natec Medical Ltd (US)
- NeuroVasc Technologies, Inc. (US)
- NexGen Medical Systems (US)
- Optimed (Germany)
- Oxford Endovascular Ltd (RA)
- Penumbra Inc. (US)
- Perflow Medical Ltd (Israel)
- Phenox GmbH (Germany)
- Rapid Medical Ltd (Israel)
- Neurovascular Rist (US)
- Sequent Medical, Inc (US)
- Medical Memory Inventor Inc. (US)
- Siemens Health Professionals (Germany)
- Silk Road Medical Inc. (US)
- Spartan Micro, Inc. (US)
- Stryker Corporation (US)
- Terumo (Microvention) (Japan)
- Varian Medical Systems (US)
- Vention (US)
- Vesalio (US)
- WL Gore & Associates. (US)
- Wallaby Medical (China)
- eLum Technologies, Inc. (US)
For more information about this report, visit https://www.researchandmarkets.com/r/mxqhvw
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We bring you the latest data on international and regional markets, key industries, major companies, new products and the latest trends.
Contact the media:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For EST Office Hours Call + 1-917-300-0470
For US / CAN Toll Free Call + 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Fax USA: 646-607-1907
Fax (outside the US): +353-1-481-1716
SOURCE Research and Markets
Related Links
http://www.researchandmarkets.com